Fulgent Genetics Net Income 2015-2024 | FLGT

Fulgent Genetics net income from 2015 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Fulgent Genetics Annual Net Income
(Millions of US $)
2023 $-168
2022 $143
2021 $507
2020 $214
2019 $-0
2018 $-6
2017 $-3
2016 $-5
2015 $-8
2014 $-4
Fulgent Genetics Quarterly Net Income
(Millions of US $)
2024-09-30 $-15
2024-06-30 $-9
2024-03-31 $-13
2023-12-31 $-128
2023-09-30 $-13
2023-06-30 $-11
2023-03-31 $-15
2022-12-31 $-24
2022-09-30 $2
2022-06-30 $12
2022-03-31 $154
2021-12-31 $104
2021-09-30 $123
2021-06-30 $80
2021-03-31 $201
2020-12-31 $166
2020-09-30 $47
2020-06-30 $3
2020-03-31 $-2
2019-12-31 $-0
2019-09-30 $1
2019-06-30 $0
2019-03-31 $-2
2018-12-31 $-2
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-1
2017-06-30 $-0
2017-03-31 $0
2016-12-31 $1
2016-09-30 $-1
2016-06-30 $-5
2016-03-31 $-1
2015-12-31
2015-09-30 $0
2015-06-30
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.563B $0.289B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00